Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Macrophage Activation, Assessed by Macrophage Markers Soluble CD163 and Soluble CD206, as Indication of Early Liver Cell Damage in Paracetamol Overdose

NCT03679442 is registered in ClinicalTrials.gov with University of Aarhus as lead sponsor.

NCT NCT03679442
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03679442 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Macrophage Activation, Assessed by Macrophage Markers Soluble CD163 and Soluble CD206, as Indication of Early Liver Cell Damage in Paracetamol Overdose
Lead sponsor
University of Aarhus
Phase
Phase 1
Overall status
Completed
Start date
September 8, 2014
Completion date
February 18, 2017
Enrollment
16 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

drug-induced acute liver injury